Multiplexed molecular profiling of lung cancer using pleural effusion

Journal of Thoracic Oncology

Volumn 9, Issue 7, 2014, Pages 1048-1052

  Akamatsu, Hiroaki ^a,b,c   Koh, Yasuhiro ^a,b,c   Kenmotsu, Hirotsugu ^a   Naito, Tateaki ^a   Serizawa, Masakuni ^b   Kimura, Madoka ^a,d   Mori, Keita ^b   Imai, Hisao ^a   Ono, Akira ^a   Shukuya, Takehito ^a,e   Taira, Tetsuhiko ^a   Murakami, Haruyasu ^a   Ohde, Yasuhisa ^b   Endo, Masahiro ^b   Nakajima, Takashi ^b   Takahashi, Toshiaki ^a   Yamamoto, Nobuyuki ^a,c  

^a Division of Esophageal Surgery Shizuoka Cancer Center   (United States)

^b SHIZUOKA CANCER CENTER   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^d OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

Author keywords

Driver mutation; Lung cancer; Multiplexed molecular testing; Pleural effusion

Indexed keywords

CRIZOTINIB; ERLOTINIB; EML4-ALK FUSION PROTEIN, HUMAN; GUANOSINE TRIPHOSPHATASE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NRAS PROTEIN, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PIK3CA PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADULT; AGED; AKT1 GENE; ALK GENE; ARTICLE; BRAF GENE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; EGFR GENE; FEMALE; FGFR1 GENE; FGFR2 GENE; FUSION GENE; GENE; GENE REARRANGEMENT; GENOTYPE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEK1 GENE; MET GENE; MUTATIONAL ANALYSIS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE NEU; ONCOGENE RET; PIK3CA GENE; PLEURA EFFUSION; PRIORITY JOURNAL; PTEN GENE; PYROSEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROS1 GENE; VERY ELDERLY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE FUSION; GENETICS; GENOTYPING TECHNIQUE; LUNG TUMOR; MIDDLE AGED; MUTATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE FUSION; GENOTYPE; GENOTYPING TECHNIQUES; GTP PHOSPHOHYDROLASES; HUMANS; LUNG NEOPLASMS; MALE; MAP KINASE KINASE 1; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS, FUSION; PHOSPHATIDYLINOSITOL 3-KINASES; PLEURAL EFFUSION; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84902485736     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000203     Document Type: Article

References (13)

1. Maemondo M, Inoue A, Kobayashi K, et al.; North-East Japan Study Group. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med 2010;362:2380-2388
2. Soda M, Choi YL, Enomoto M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007;448:561-566
3. Bergethon K, Shaw AT, Ou SH, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012;30:863-870
4. Kohno T, Ichikawa H, Totoki Y, et al. KIF5B-RET fusions in lung adenoarcinoma. Nat Med 2012;18:375-377
5. Pass HI, Carbone DP, Johnson DH, et al. Principles and Practice of Lung Cancer. Fourth edition. Lippincott Williams and Wilkins; 2010
6. Sequist LV, Heist RS, Shaw AT, et al. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol 2011;22:2616-2624
7. Pao W, Chmielecki J. Rational, biologically based treatment of EGFRmutant non-small-cell lung cancer. Nat Rev Cancer 2010;10:760-774
8. Goto K, Satouchi M, Ishii G, et al. An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 2012;23:2914-2919
9. Yeo CD, Kim JW, Kim KH, et al. Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing. Lung Cancer 2013;81:207-212
10. Buttitta F, Felicioni L, Del Grammastro M, et al. Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by nextgeneration sequencing. Clin Cancer Res 2013;19:691-698
11. Vignot S, Frampton GM, Soria JC, et al. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer. J Clin Oncol 2013;31:2167-2172
12. Dawson SJ, Tsui DW, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;368:1199-1209
13. Sequist LV, Waltman BA, Dias-Santagata D, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 2011;3:75ra26.